Insights

Gathering insights about SiLo…

Similar companies to SiLo

SiLo Tech Stack

SiLo uses 8 technology products and services including Open Graph, Salesforce, MySQL, and more. Explore SiLo's tech stack below.

Open Graph
Content Management System
Salesforce
Customer Relationship Management
MySQL
Database
Google Fonts API
Font Scripts
HubSpot
Marketing Automation
JavaScript
Programming Languages
WayUp
Recruitment Marketing
Blazor
Web Frameworks

Media & News

Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update
Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 518,127 shares, a drop of 12.5% from the December 31st total of 592,133 shares. Approximately 4.0% of the company's shares are sold short. Based on an
Feb 05, 2026 | www.defenseworld.net
Silo Pharma (NASDAQ:SILO) Stock Price Up 3.6% – Still a Buy?
Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) shares traded up 3.6% during trading on Thursday. The stock traded as high as $0.3754 and last traded at $0.3689. 45,852 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 142,715 shares. The stock had previously closed at $0.3562.
Jan 23, 2026 | www.defenseworld.net
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety SARASOTA, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a diversified developmental stage biopharmaceutical and cryptocurrency treasury company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a non-binding Letter of Intent (“LOI”) with Allucent (US) LLC (“Allucent”), a global clinical research organization (CRO), to provide clinical research services for two planned Phase 1 studies evaluating its SPC-15 nasal spray in healthy subjects: an Open-Label, Single Ascending Dose (SAD) study and an Open-Label, Multiple Ascending Dose (MAD) study. Allucent and Silo intend to negotiate a Master Services Agreement and project-specific Work Order to cover a comprehensive scope of activities across clinical operations, pharmacovigilance, data management, biostatistics, clinical pharmacology modeling & simulation, and medical writing to support execution and reporting of the Phase 1 program.
Dec 30, 2025 | www.globenewswire.com
Contrasting Silo Pharma (NASDAQ:SILO) & MannKind (NASDAQ:MNKD)
MannKind (NASDAQ: MNKD - Get Free Report) and Silo Pharma (NASDAQ: SILO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Earnings and Valuation This table compares MannKind and
Nov 21, 2025 | www.defenseworld.net
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Allucent, a global full-service clinical research organization (CRO), to support the Company's final preparations and planned submission of its investigational new drug application (IND) to the FDA for a Phase 1 clinical trial of its intranasal prophylactic SPC-15 as a treatment for PTSD. The Company currently expects to submit the IND in 2026 and commence its first-in-human (FIH) SPC-15 trial subsequent to FDA approval.
Nov 17, 2025 | www.globenewswire.com
Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
Investment vehicle provides diversified exposure to real-world assets and expected to reduce portfolio volatility Strategic allocation aligns with Silo's objective of generating yield while maintaining a hedge against downside risk New York, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Alphaledger/Simplify Target 12% Distribution Fund LLC (the “Alphaledger T12 Fund”) as a core component of its real-world asset (RWA) investment strategy on the Solana blockchain. This strategic allocation aligns with Silo's approach to treasury diversification and digital asset integration.
Oct 29, 2025 | www.globenewswire.com
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence before year-end SARASOTA, FL, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced a comprehensive update detailing progress for lead candidate SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD) and stress-induced anxiety, and key achievements under Silo's new digital assets treasury platform launched in August 2025. Biopharmaceutical Platform: Silo is advancing SPC-15, its lead therapeutic candidate, through the final preparations requiredprior to submitting an investigational new drug application (IND) to the FDA.
Oct 23, 2025 | www.globenewswire.com

SiLo's Email Address Formats

SiLo uses at least 1 format(s):

SiLo Email Formats	Example	Percentage
First@shipsilo.com	John@shipsilo.com	47%
Last@shipsilo.com	Doe@shipsilo.com	3%
First@shipsilo.com	John@shipsilo.com	47%
Last@shipsilo.com	Doe@shipsilo.com	3%

Frequently Asked Questions

Where is SiLo's headquarters located?

SiLo's main headquarters is located at 414 Union Street Suite 1210 Nashville, Tennessee 37219 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is SiLo's stock symbol?

SiLo is a publicly traded company; the company's stock symbol is SILO.

What is SiLo's official website and social media links?

SiLo's official website is shipsilo.com and has social profiles on LinkedIn.

What is SiLo's NAICS code?

SiLo's NAICS code is 48-49 - Transportation and Warehousing.

How many employees does SiLo have currently?

As of February 2026, SiLo has approximately 85 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Vp Partner Solutions / Co-Founder: L. H.President & Co-Founder: A. S.Head Of People And Culture: C. G.. Explore SiLo's employee directory with LeadIQ.

What industry does SiLo belong to?

SiLo operates in the Transportation, Logistics, Supply Chain and Storage industry.

What technology does SiLo use?

SiLo's tech stack includes Open GraphSalesforceMySQLGoogle Fonts APIHubSpotJavaScriptWayUpBlazor.

What is SiLo's email format?

SiLo's email format typically follows the pattern of First@shipsilo.com. Find more SiLo email formats with LeadIQ.

When was SiLo founded?

SiLo was founded in 2020.

SiLo

Q: What is SiLo's official website and social media links?

SiLo's official website is shipsilo.com. SiLo has social profiles on LinkedIn.

Q: How many employees does SiLo have currently?

SiLo has approximately 85 employees.

Q: What technology does SiLo use?

SiLo's tech stack includes X-Content-Type-Options, Google Analytics, C#, Priority Hints, Google Workspace.

Transportation, Logistics, Supply Chain and StorageTennessee, United States51-200 Employees

At SiLo, we deliver strategic solutions specifically tailored to optimize your business logistics. We prioritize relationships and partnerships through thorough communication and transparent relationships so you can feel confident throughout the entire process. Whether it is a heavy-haul, time-critical, oversize, multi-stop shipment, full truckload, partial truckload, open deck, van or all the above, SiLo has got you covered. It’s simple.

Company Overview

Headquarters: 414 Union Street Suite 1210 Nashville, Tennessee 37219 United States
Website: shipsilo.com
Stock Symbol: SILO
NAICS Code: 48-49 - Transportation and Warehousing
Founded: 2020
Employees: 51-200

Media & News

Funding & Financials

$25M$50M
SiLo's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
SiLo's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to SiLo

NEXT Trucking

Werner Enterprises

Transfix

Convoy

Loadsmart

Echo Global Logistics

Coyote Logistics

Schneider

SiLo Tech Stack

Media & News

Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma (NASDAQ:SILO) Stock Price Up 3.6% – Still a Buy?

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Contrasting Silo Pharma (NASDAQ:SILO) & MannKind (NASDAQ:MNKD)

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

SiLo's Email Address Formats

Frequently Asked Questions

Where is SiLo's headquarters located?

What is SiLo's stock symbol?

What is SiLo's official website and social media links?

What is SiLo's NAICS code?

How many employees does SiLo have currently?

What industry does SiLo belong to?

What technology does SiLo use?

What is SiLo's email format?

When was SiLo founded?

SiLo

Company Overview

Media & News

Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma (NASDAQ:SILO) Stock Price Up 3.6% – Still a Buy?

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?